Table 2. Self-reported changes for psychological symptoms/complaints scores assessed based on the psychological questionnaire (mITT population).
| Parameter | Control (N=35) |
Sham Control (N=40) |
Biofield Energy Therapy (N=39) |
|||
|---|---|---|---|---|---|---|
| Day 90 (Mean$ ± SD) |
Day 180 (Mean$ ± SD) | Day 90 (Mean$ ± SD) | Day 180 (Mean$ ± SD) | Day 90 (Mean$ ± SD) |
Day 180 (Mean$ ± SD) |
|
| Tiredness /fatigue/pain |
-0.2 ± 0.79 | -0.1 ± 0.78 | 0.3 ± 0.99 | 0.2 ± 1.08** | -11.5 ± 1.02****/#### | -15.4 ± 0.55****/#### |
| Sleep disturbances | -0.4 ± 0.74 | -0.1 ± 0.60 | 0.4 ± 1.21 | 0.3 ± 1.28 | -11.3 ± 0.87****/#### | -15.4 ± 0.49****/#### |
| Stress | -0.7 ± 1.05 | -0.1 ± 0.55 | 0.1 ± 0.52 | 0.1 ± 0.55** | -11.1 ± 0.97****/#### | -15.1 ± 0.68****/#### |
| Lack of cognition and memory |
-0.3 ± 0.87 | -0.2 ± 0.82 | 0.4 ± 1.00 | 0.3 ± 1.02 | -11.2 ± 1.02****/#### | -15.3 ± 0.58****/#### |
| Mental restlessness | -0.6 ± 1.09 | -0.2 ± 0.45 | 0.1 ± 0.38* | 0.0 ± 0.42 | -11.3 ± 0.80****/#### | -15.3 ± 0.44****/#### |
| Emotional trauma | -0.5 ± 1.01 | -0.1 ± 0.74 | -0.2 ± 0.50 | -0.2 ± 0.43* | -11.6 ± 1.02****/#### | -15.4 ± 0.50****/#### |
| Lack of inspiration/ motivation/ enthusiasm |
-0.6 ± 0.91 | -0.2 ± 0.38 | 0.1 ± 0.47 | 0.1 ± 0.44 | -11.6 ± 1.09****/#### | -15.4 ± 0.49****/#### |
| Lack of Perception | -0.3 ± 1.15 | 0.1 ± 0.74 | 0.7 ± 2.15 | 0.6 ± 2.17 | -11.2 ± 0.93****/#### | -15.2 ± 0.67****/#### |
| Lack of Relationships & Social | -0.5 ± 1.17 | 15.6 ± 0.65 | -0.1 ± 0.44 | 15.0 ± 0.32** | -11.1 ± 1.07****/#### | 0.1 ± 0.27****/#### |
| Low libido | -0.2 ± 0.80 | -0.0 ± 0.51 | 0.5 ± 1.99 | 0.6 ± 1.97 | -11.3 ± 0.96****/#### | -15.2 ± 0.67****/#### |
| Financial crises & dissatisfaction |
-0.6 ± 0.97 | -0.1 ± 0.68 | 0.0 ± 0.36 | 0.0 ± 0.51** | -10.9 ± 0.97****/#### | -15.0 ± 0.56****/#### |
| Menstrual Disorders | -0.4 ± 1.23 | 0.2 ± 0.81 | 0.2 ± 1.10 | 0.2 ± 1.10 | -11.2 ± 0.70****/#### | -15.3 ± 0.57****/#### |
All the values are represented as Mean ± SD of CFB (change from baseline); $CFB = (post baseline – baseline); N = number of subjects in the respective treatment group. Day 0 considered as the baseline. Statistical significance p-value was calculated for between comparison using one-way Repeated Measure Analysis of Covariance (RM-ANCOVA). *p <.05, **p <.01, and ****p <.0001 vs. control group; ####p <.0001 vs. sham control group.